Alexa Fluor® 568 Anti-CD64 抗体 [EPR4623]
Alexa Fluor® 568 Anti-CD64 antibody [EPR4623]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CD64 antibody - conjugated to Alexa Fluor® 568.
別名を表示する
CD64, FCG1, FCGR1, IGFR1, FCGR1A, High affinity immunoglobulin gamma Fc receptor I, IgG Fc receptor I, Fc-gamma RI, Fc-gamma RIA, FcRI, FcgammaRIa
関連する標識済み抗体及び組成の異なる製品 (8)
-
Anti-CD64 antibody [EPR4623]
-
660 APC
APC Anti-CD64 antibody [EPR4623]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD64 antibody [EPR4623]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD64 antibody [EPR4623]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD64 antibody [EPR4623]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD64 antibody [EPR4623]
-
578 PE
PE Anti-CD64 antibody [EPR4623]
-
Anti-CD64 antibody [EPR4623] - BSA and Azide free
下記製品にもご興味をお持ちいただけるかもしれません:
こちらの製品も推奨する理由
この製品は、同様の実験や関連する研究で広く使用されていることから推奨させていただいております。
お客様の実験に適するかご確認いただくため、必ず製品データシートをご確認いただくことをお勧めいたします。ご不明点等ございましたら、テクニカルサポートチームまでお問い合わせください。
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD64 expression involves the binding of IgG which serves as a pivotal mechanism to facilitate phagocytosis and clearance of opsonized pathogens. CD64 does not operate solely; it is part of a larger receptor family that includes other Fc gamma receptors like CD16 and CD32. The regulation of CD64 differs from its relatives due to its higher affinity for IgG. This attribute enables CD64 to play a more significant role in triggering immune responses especially during infections and inflammatory processes.
Pathways
CD64 participates in the immune response pathway and is critical in the regulation of inflammatory responses. Key proteins interacting with CD64 in these pathways include the aforementioned CD16 and CD32 forming a network that ensures efficient immune system activation. The interaction with IgG and subsequent signal transduction underpin the receptor's functionality in these pathways harmonizing innate and adaptive immune responses.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
Abcam product promise
関連製品
Alternative Version
Primary Antibodies
AB216856
Anti-CD64 antibody [EPR4623] - BSA and Azide free
primary-antibodies
cd64-antibody-epr4623-bsa-and-azide-free-ab216856
0
(0 reviews)
Alternative Version
Primary Antibodies
AB246692
Anti-CD64 antibody [EPR4623] - Low endotoxin, Azide free
primary-antibodies
cd64-antibody-epr4623-low-endotoxin-azide-free-ab246692
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com